Do cytomegalovirus infections affect the daratumumab treatment course in multiple myeloma patients? ¿ Literature review Luana Mota Ferreira; Jaderson Lima Cerezer; Mailine Gehrcke;

Treatment of relapsed, refractory multiple myeloma: focus on new drugs Angelo Maiolino;

PDCD1 VARIANTS ARE INDEPENDENT PROGNOSTIC FACTORS IN PATIENTS WITH HEAD AND NECK SQUAMOUS CELL CARCINOMA Matheus Yung Perin; Daniele Daiane Affonso; Carlos Takahiro Chone; Gustavo Jacob Lourenço; Carmen Silvia Passos Lima;